Private Equity Sixth Street Partners-Backed Caris Life Sciences Agreed to Pay Fines over U.S. Scheme to Defraud Medicare
Posted on 07/08/2022
In May 2021, Caris Life Sciences, Inc., an Irving, Texas-based precision medicines developer, raised US$ 830 million in growth equity funding at a US$ 7.83 billion post-money valuation. Sixth Street Partners led, and was joined by T. Rowe Price, Silver Lake Partners, Fidelity, Coatue, Columbia Threadneedle Investments, Canada Pension Plan Investment Board (CPPIB), Millennium Management,…
